Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1308 to 1357 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
654\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylserine receptor; phosphatidylserine receptor beta. [source:refseq;acc:nm\_015167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.139\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.117\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
655\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 1 (p62(dok)) (downstream of tyrosine kinase 1) (pp62). [source:swissprot;acc:q99704]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q8n1c3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.256\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
202.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
12.116\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
656\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p47869]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase frk (ec 2.7.1.112) (nuclear tyrosine protein kinase rak). [source:swissprot;acc:p42685]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
657\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-6 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q16445]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.116\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin iii. [source:swissprot;acc:o14994]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
229.072\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
216.576\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
658\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p18507]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.256\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
202.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
12.116\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
659\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-4 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p48169]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif 1 (hairy and enhancer of split related-1) (hesr-1) (cardiovascular helix-loop-helix factor 2) (hes-related repressor protein 2 herp2). [source:swissprot;acc:q9y5j3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
229.072\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
216.576\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
660\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin binding lim protein 2. [source:refseq;acc:nm\_032432]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor epsilon subunit precursor (gaba(a) receptor). [source:swissprot;acc:p78334]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
214.256\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
202.14\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
12.116\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
661\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p14867]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif-like. [source:refseq;acc:nm\_014571]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
662\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p34903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.116\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin ii. [source:swissprot;acc:q92777]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
229.072\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
216.576\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
663\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial ribosome recycling factor. [source:refseq;acc:nm\_138777]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase b14 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b14) (ci-b14). [source:swissprot;acc:p56556]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.141\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.115\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
664\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal targeting signal 1 receptor (peroxismore receptor 1) (peroxisomal c-terminal targeting signal import receptor) (pts1-bp) (peroxin-5) (pts1 receptor). [source:swissprot;acc:p50542]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
similar to expressed sequence aa415817. [source:sptrembl;acc:q8n4q9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.256\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.141\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.115\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
665\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hairy/enhancer-of-split related with yrpw motif 2; gridlock; hes-related repressor protein 1. [source:refseq;acc:nm\_012259]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-d9 (hox-4c) (hox-5.2). [source:swissprot;acc:p28356]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
214.254\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.166\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.088\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
666\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 2 (eif-3 beta) (eif3 p36) (eif3i) (tgf-beta receptor interacting protein 1) (trip-1). [source:swissprot;acc:q13347]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
250.465\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
238.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.085\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor hes-1 (hairy and enhancer of split 1) (hairy- like) (hhl) (hairy homolog). [source:swissprot;acc:q14469]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
229.072\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
216.576\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
667\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
delta3,5-delta2,4-dienoyl-coa isomerase, mitochondrial precursor (ec 5.3.3.-). [source:swissprot;acc:q13011]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
trinucleotide repeat containing 15. [source:refseq;acc:nm\_015575]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
250.465\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
238.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.085\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
668\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
actin-binding lim protein 1 isoform a; lim actin-binding protein 1; limatin; actin-binding lim protein. [source:refseq;acc:nm\_002313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ftsj homolog 3; likely ortholog of mouse ectoplacental cone, invasive trophoblast giant cells, extraembryonic ectoderm and chorion sequence 3. [source:refseq;acc:nm\_017647]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
244.495\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.419\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
12.076\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
669\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
presenilin-like protein 2 (ec 3.4.99.-) (sppl2a protein). [source:swissprot;acc:q8tct8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
232.601\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
244.534\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.933\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
synapsin i (brain protein 4.1). [source:swissprot;acc:p17600]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
229.072\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0577\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
670\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
autoantigen ngp-1. [source:swissprot;acc:q13823]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
250.302\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.817\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05694\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
gtp-binding nuclear protein ran (tc4) (ran gtpase) (androgen receptor- associated protein 24). [source:swissprot;acc:p17080]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.601\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
244.534\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.933\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
671\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleotide-binding protein 1 (nbp 1). [source:swissprot;acc:p53384]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.739\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.398\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05688\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
presenilin-like protein 1 (ec 3.4.99.-) (sppl2b protein). [source:swissprot;acc:q8tct7]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.601\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
244.534\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.933\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
672\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dok-like protein. [source:refseq;acc:nm\_024872]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.882\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleotide binding protein 2 (nbp 2). [source:swissprot;acc:q9y5y2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.739\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.398\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05688\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
673\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 2 (p56(dok-2)) (downstream of tyrosine kinase 2). [source:swissprot;acc:o60496]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.882\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peripheral plasma membrane protein cask (ec 2.7.1.-) (hcask) (calcium/calmodulin-dependent serine protein kinase) (lin-2 homolog). [source:swissprot;acc:o14936]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.497\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.355\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05664\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
674\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 1 (p62(dok)) (downstream of tyrosine kinase 1) (pp62). [source:swissprot;acc:q99704]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.882\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hypoxia-inducible factor-3 alpha isoform a; inhibitory pas domain protein. [source:refseq;acc:nm\_152794]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
226.497\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
214.355\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.05664\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
675\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
single-minded homolog 1. [source:swissprot;acc:p81133]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase frk (ec 2.7.1.112) (nuclear tyrosine protein kinase rak). [source:swissprot;acc:p42685]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.504\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.622\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.882\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
676\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 19 kda polypeptide (ec 2.7.7.6) (rpb7). [source:swissprot;acc:p52433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
232.469\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
245.613\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05654\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein p0-like protein; 60s acidic ribosomal protein po; ribosomal protein, large, p0-like. [source:refseq;acc:nm\_016183]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
245.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
257.636\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.796\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
677\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fibrillarin (34 kda nucleolar scleroderma antigen). [source:swissprot;acc:p22087]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
245.246\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
233.483\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.763\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm4 (glycine-rich protein) (grp). [source:swissprot;acc:q9y4z0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.944\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.745\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05628\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
678\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidylprolyl isomerase-like 4; cyclophilin-type peptidyl-prolyl cis-trans isomerase; ppiase; serologically defined breast cancer antigen ny-br-18. [source:refseq;acc:nm\_139126]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.135\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
214.405\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
11.73\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 5. [source:swissprot;acc:q9y5x3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
208.482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
220.175\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05609\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
679\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c4 (hox-3e) (cp19). [source:swissprot;acc:p09017]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
132.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
125.389\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.05602\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/